Literature DB >> 25135692

CD34(+)CD38(-)CD58(-) cells are leukemia-propagating cells in Philadelphia chromosome-positive acute lymphoblastic leukemia.

Y Kong1, Y-J Chang1, Y-R Liu1, Y-Z Wang1, Q Jiang1, H Jiang1, Y-Z Qin1, Y Hu2, Y-Y Lai1, C-W Duan3, D-L Hong3, X-J Huang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 25135692     DOI： 10.1038/leu.2014.228

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  15 in total

1.  Rapid myeloerythroid repopulation after intrafemoral transplantation of NOD-SCID mice reveals a new class of human stem cells.

Authors:  Frédéric Mazurier; Monica Doedens; Olga I Gan; John E Dick
Journal:  Nat Med       Date:  2003-07       Impact factor: 53.440

Review 2.  B-cell acute lymphoblastic leukaemia: towards understanding its cellular origin.

Authors:  César Cobaleda; Isidro Sánchez-García
Journal:  Bioessays       Date:  2009-06       Impact factor: 4.345

3.  Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.

Authors:  Andrew J Gentles; Sylvia K Plevritis; Ravindra Majeti; Ash A Alizadeh
Journal:  JAMA       Date:  2010-12-22       Impact factor: 56.272

4.  Identification of novel markers for monitoring minimal residual disease in acute lymphoblastic leukemia.

Authors:  J S Chen; E Coustan-Smith; T Suzuki; G A Neale; K Mihara; C H Pui; D Campana
Journal:  Blood       Date:  2001-04-01       Impact factor: 22.113

5.  Stem cell gene expression programs influence clinical outcome in human leukemia.

Authors:  Kolja Eppert; Katsuto Takenaka; Eric R Lechman; Levi Waldron; Björn Nilsson; Peter van Galen; Klaus H Metzeler; Armando Poeppl; Vicki Ling; Joseph Beyene; Angelo J Canty; Jayne S Danska; Stefan K Bohlander; Christian Buske; Mark D Minden; Todd R Golub; Igor Jurisica; Benjamin L Ebert; John E Dick
Journal:  Nat Med       Date:  2011-08-28       Impact factor: 53.440

6.  Chemotherapy-resistant human AML stem cells home to and engraft within the bone-marrow endosteal region.

Authors:  Fumihiko Ishikawa; Shuro Yoshida; Yoriko Saito; Atsushi Hijikata; Hiroshi Kitamura; Satoshi Tanaka; Ryu Nakamura; Toru Tanaka; Hiroko Tomiyama; Noriyuki Saito; Mitsuhiro Fukata; Toshihiro Miyamoto; Bonnie Lyons; Koichi Ohshima; Naoyuki Uchida; Shuichi Taniguchi; Osamu Ohara; Koichi Akashi; Mine Harada; Leonard D Shultz
Journal:  Nat Biotechnol       Date:  2007-10-21       Impact factor: 54.908

7.  A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.

Authors:  T Lapidot; C Sirard; J Vormoor; B Murdoch; T Hoang; J Caceres-Cortes; M Minden; B Paterson; M A Caligiuri; J E Dick
Journal:  Nature       Date:  1994-02-17       Impact factor: 49.962

8.  Expression of surface adhesion molecules CD54 (ICAM-1) and CD58 (LFA-3) in adult acute leukemia: relationship with initial characteristics and prognosis.

Authors:  E Archimbaud; X Thomas; L Campos; J P Magaud; J F Doré; D Fiere
Journal:  Leukemia       Date:  1992-04       Impact factor: 11.528

9.  A novel monoclonal antibody against murine IL-2 receptor beta-chain. Characterization of receptor expression in normal lymphoid cells and EL-4 cells.

Authors:  T Tanaka; M Tsudo; H Karasuyama; F Kitamura; T Kono; M Hatakeyama; T Taniguchi; M Miyasaka
Journal:  J Immunol       Date:  1991-10-01       Impact factor: 5.422

10.  Partially matched related donor transplantation can achieve outcomes comparable with unrelated donor transplantation for patients with hematologic malignancies.

Authors:  Huang Xiao-Jun; Xu Lan-Ping; Liu Kai-Yan; Liu Dai-Hong; Wang Yu; Chen Huan; Chen Yu-Hong; Han Wei; Wang Jing-Zhi; Chen Yao; Zhang Xiao-Hui; Shi Hong-Xia; Wang Feng-Rong; Tang Fei-Fei
Journal:  Clin Cancer Res       Date:  2009-07-07       Impact factor: 12.531
View more
  8 in total

1.  Presence of CD34(+)CD38(-)CD58(-) leukemia-propagating cells at diagnosis identifies patients at high risk of relapse with Ph chromosome-positive ALL after allo-hematopoietic SCT.

Authors:  Y Kong; L-P Xu; Y-R Liu; Y-Z Qin; Y-Q Sun; Y Wang; H Jiang; Q Jiang; H Chen; Y-J Chang; X-J Huang
Journal:  Bone Marrow Transplant       Date:  2014-12-08       Impact factor: 5.483

2.  BCR/ABL can promote CD19+ cell growth but not render them long-term stemness.

Authors:  Donghe Li; Xuemei Zhao; Ruihong Zhang; Bo Jiao; Ping Liu; Ruibao Ren
Journal:  Stem Cell Investig       Date:  2016-11-30

3.  Increased reactive oxygen species and exhaustion of quiescent CD34-positive bone marrow cells may contribute to poor graft function after allotransplants.

Authors:  Yuan Kong; Yang Song; Yue Hu; Min-Min Shi; Yu-Tong Wang; Yu Wang; Xiao-Hui Zhang; Lan-Ping Xu; Kai-Yan Liu; Hong-Kui Deng; Xiao-Jun Huang
Journal:  Oncotarget       Date:  2016-05-24

Review 4.  Cancer stem cell mobilization and therapeutic targeting of the 5T4 oncofetal antigen.

Authors:  Richard Harrop; Eric O'Neill; Peter L Stern
Journal:  Ther Adv Vaccines Immunother       Date:  2019-01-25

Review 5.  Ectonucleotidases in Blood Malignancies: A Tale of Surface Markers and Therapeutic Targets.

Authors:  Tiziana Vaisitti; Francesca Arruga; Giulia Guerra; Silvia Deaglio
Journal:  Front Immunol       Date:  2019-10-04       Impact factor: 7.561

Review 6.  Stem Cell Hierarchy and Clonal Evolution in Acute Lymphoblastic Leukemia.

Authors:  Fabian Lang; Bartosch Wojcik; Michael A Rieger
Journal:  Stem Cells Int       Date:  2015-07-06       Impact factor: 5.443

7.  Ruxolitinib/nilotinib cotreatment inhibits leukemia-propagating cells in Philadelphia chromosome-positive ALL.

Authors:  Yuan Kong; Yi-Lin Wu; Yang Song; Min-Min Shi; Xie-Na Cao; Hong-Yan Zhao; Ya-Zhen Qin; Yue-Yun Lai; Hao Jiang; Qian Jiang; Xiao-Jun Huang
Journal:  J Transl Med       Date:  2017-08-30       Impact factor: 5.531

8.  Leukemia propagating cells in Philadelphia chromosome-positive ALL: a resistant phenotype with an adverse prognosis.

Authors:  Nadia El-Menshawy; Sherin M Abd-Aziz; Enas M Elkhamisy; Mohammed A Ebrahim
Journal:  Blood Res       Date:  2018-06-25
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.